15:53 Tue 11 Feb 2020
Goldilocks Therapeutics Inc CEO Arthur Klausner sat down with Proactive's Christine Corrado at BIO CEO in New York.
The New York-based early-stage bio-pharmaceutical company's kidney-targeting "mesoscale nanoparticle" technology was developed at Memorial Sloan Kettering Cancer Center for the prevention and treatment of acute kidney injury and polycystic kidney disease.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Energy
Mining
Smart Metering Systems PLC's (LON:SMS) chief executive Alan Foy says it has £76mln indexed linked annualised recurring revenues on the books with at least an additional £40mln in waiting when it converts its minimum secured order book of 2mln to smart meters. Foy explains that the company gets...
Mining
AfriTin Mining CEO says operations are coming along nicely with 35...
Prev article
